Skip to main content
OpenTrials

Clinical trial condition

Chronic Myelogenous Leukemia

Explore clinical trials studying Chronic Myelogenous Leukemia. Study availability and eligibility vary by location and protocol.

112 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Chronic Myelogenous Leukemia trial results

Completed

Safety Study of AP24534 to Treat Chronic Myelogenous Leukemia (CML) and Other Hematological Malignancies

NCT00660920

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +14 more
Locations
  • ARIAD Investigational Site #075 San Francisco, California, United States
  • ARIAD Investigational Site #011 Ann Arbor, Michigan, United States
  • ARIAD Investigational Site #048 Portland, Oregon, United States
  • ARIAD Investigational Site #076 Nashville, Tennessee, United States
View Trial Details
Completed

Nilotinib Versus Standard Imatinib (400/600 mg Every Day (QD)) Comparing the Kinetics of Complete Molecular Response for Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) Pts With Evidence of Persistent Leukemia by Real-time Quantitative Polymerase Chain Reaction (RQ-PCR)

NCT00760877

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +11 more
Locations
  • Novartis Investigative Site Caba, Buenos Aires, Argentina
  • Novartis Investigative Site St Leonards, New South Wales, Australia
  • Novartis Investigative Site Westmead, New South Wales, Australia
  • Novartis Investigative Site Herston, Queensland, Australia
View all 30 locations
View Trial Details

Related conditions